The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder
Open accessAbstract
Omega-3 polyunsaturated fatty acid (PUFA) supplementation has been proposed as (adjuvant) treatment for major depressive disorder (MDD). In the present meta-analysis, we pooled randomized placebo-controlled trials assessing the effects of omega-3 PUFA supplementation on depressive symptoms in MDD. Moreover, we performed meta-regression to test whether supplementation effects depended on eicosapentaenoic acid (EPA) or docosahexaenoic acid dose, their ratio, study duration, participants’ age, percentage antidepressant users, baseline MDD symptom severity, publication year and study quality. To limit heterogeneity, we only included studies in adult patients with MDD assessed using standardized clinical interviews, and excluded studies that specifically studied perinatal/perimenopausal or comorbid MDD. Our PubMED/EMBASE search resulted in 1955 articles, from which we included 13 studies providing 1233 participants. After taking potential publication bias into account, meta-analysis showed an overall beneficial effect of omega-3 PUFAs on depressive symptoms in MDD (standardized mean difference=0.398 (0.114–0.682), P=0.006, random-effects model). As an explanation for significant heterogeneity (I2=73.36, P<0.001), meta-regression showed that higher EPA dose (β=0.00037 (0.00009–0.00065), P=0.009), higher percentage antidepressant users (β=0.0058 (0.00017–0.01144), P=0.044) and earlier publication year (β=−0.0735 (−0.143 to 0.004), P=0.04) were significantly associated with better outcome for PUFA supplementation. Additional sensitivity analyses were performed. In conclusion, present meta-analysis suggested a beneficial overall effect of omega-3 PUFA supplementation in MDD patients, especially for higher doses of EPA and in participants taking antidepressants. Future precision medicine trials should establish whether possible interactions between EPA and antidepressants could provide targets to improve antidepressant response and its prediction. Furthermore, potential long-term biochemical side effects of high-dosed add-on EPA supplementation should be carefully monitored.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2009) · doi:10.1002/9780470743386 · Cited by 14,225
Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2021) · doi:10.1002/9781119558378 · Cited by 9,799
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829
Polyunsaturated fatty acids and their metabolites in brain function and disease
Bazinet, R. P., & Layé, S. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3820 · Cited by 1,605
Scales to Assess the Quality of Randomized Controlled Trials: A Systematic Review
Olivo, S. A., Macedo, L. G., Gadotti, I. C., Fuentes, J., Stanton, T., & Magee, D. J. (2008) · Physical Therapy · doi:10.2522/ptj.20070147 · Cited by 829
Nemets, B., Stahl, Z., & Belmaker, R. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.3.477 · Cited by 627
Peet, M., & Horrobin, D. F. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.10.913 · Cited by 614
Omega-3 fatty acids in major depressive disorder
Su, K.-P., Huang, S.-Y., Chiu, C.-C., & Shen, W. W. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)00032-4 · Cited by 596
A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression
Lin, P.-Y., Huang, S.-Y., & Su, K.-P. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.03.018 · Cited by 530
Grosso, G., Pajak, A., Marventano, S., Castellano, S., Galvano, F., Bucolo, C., Drago, F., & Caraci, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096905 · Cited by 449
Meta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in Depression
Sublette, M. E., Ellis, S. P., Geant, A. L., & Mann, J. J. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06634 · Cited by 417
Marangell, L. B., Martinez, J. M., Zboyan, H. A., Kertz, B., Kim, H. F. S., & Puryear, L. J. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.5.996 · Cited by 380
Martins, J. G. (2009) · Journal of the American College of Nutrition · doi:10.1080/07315724.2009.10719785 · Cited by 358
Appleton, K. M., Rogers, P. J., & Ness, A. R. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28313 · Cited by 353
Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis
Bloch, M. H., & Hannestad, J. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.100 · Cited by 293
Rapaport, M. H., Nierenberg, A. A., Schettler, P. J., Kinkead, B., Cardoos, A., Walker, R., & Mischoulon, D. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.22 · Cited by 265
The Montgomery Äsberg and the Hamilton ratings of depression: A comparison of measures
Carmody, T. J., Rush, A. J., Bernstein, I., Warden, D., Brannan, S., Burnham, D., Woo, A., & Trivedi, M. H. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.04.008 · Cited by 245
Serotoninergic neurotransmission is affected by n‐3 polyunsaturated fatty acids in the rat
Kodas, E., Galineau, L., Bodard, S., Vancassel, S., Guilloteau, D., Besnard, J., & Chalon, S. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02401.x · Cited by 244
Appleton, K. M., Hayward, R. C., Gunnell, D., Peters, T. J., Rogers, P. J., Kessler, D., & Ness, A. R. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.6.1308 · Cited by 220
Jazayeri, S., Tehrani-Doost, M., Keshavarz, S. A., Hosseini, M., Djazayery, A., Amini, H., Jalali, M., & Peet, M. (2008) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670701827275 · Cited by 215
Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression
Silvers, K. M., Woolley, C. C., Hamilton, F. C., Watts, P. M., & Watson, R. A. (2005) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2004.11.004 · Cited by 207
da Silva, T. M., Munhoz, R. P., Alvarez, C., Naliwaiko, K., Kiss, Á., Andreatini, R., & Ferraz, A. C. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.03.008 · Cited by 205
Omega-3 fatty acids for depression in adults
Appleton, K. M., Sallis, H. M., Perry, R., Ness, A. R., & Churchill, R. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004692.pub4 · Cited by 180
Omega-3 Fatty Acid Augmentation of Citalopram Treatment for Patients With Major Depressive Disorder
Gertsik, L., Poland, R. E., Bresee, C., & Rapaport, M. H. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31823f3b5f · Cited by 162
The Efficacy of Omega-3 Supplementation for Major Depression
Lespérance, F., Frasure‐Smith, N., St-André, E., Turecki, G., Lespérance, P., & Wisniewski, S. R. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m05966blu · Cited by 149
Lin, P.-Y., Mischoulon, D., Freeman, M. P., Matsuoka, Y., Hibbeln, J., Belmaker, R. H., & Su, K.-P. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.111 · Cited by 145
Martins, J. G., Bentsen, H., & Puri, B. K. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.25 · Cited by 145
Carney, R. M., Freedland, K. E., Rubin, E. H., Rich, M. W., Steinmeyer, B. C., & Harris, W. S. (2009) · JAMA · doi:10.1001/jama.2009.1487 · Cited by 140
Assies, J., Mocking, R. J. T., Lok, A., Ruhé, H. G., Pouwer, F., & Schene, A. H. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12265 · Cited by 138
Self-citationGrenyer, B. F. S., Crowe, T. P., Meyer, B. J., Owen, A. J., Grigonis-Deane, E., Caputi, P., & Howe, P. R. C. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.06.004 · Cited by 136
Rondanelli, M., Giacosa, A., Opizzi, A., Pelucchi, C., Vecchia, C. L., Montorfano, G., Negroni, M., Berra, B., Politi, P., & Rizzo, A. M. (2010) · Journal of the American College of Nutrition · doi:10.1080/07315724.2010.10719817 · Cited by 119
Lucas, M., Asselin, G., Mérette, C., Poulin, M.-J., & Dodin, S. (2008) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26749 · Cited by 113
Serini, S., Fasano, E., Piccioni, E., Cittadini, A. R. M., & Calviello, G. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200314p · Cited by 108
Distinguishing Health Benefits of Eicosapentaenoic and Docosahexaenoic Acids
Russell, F. D., & Bürgin-Maunder, C. (2012) · Marine Drugs · doi:10.3390/md10112535 · Cited by 108
Mozaffari–Khosravi, H., Yassini-Ardakani, M., Karamati, M., & Shariati-Bafghi, S.-E. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.08.003 · Cited by 104
A Double-Blind, Randomized Controlled Trial of Ethyl-Eicosapentaenoate for Major Depressive Disorder
Mischoulon, D., Papakostas, G. I., Dording, C. M., Farabaugh, A. H., Sonawalla, S. B., Agoston, A. M., Smith, J., Beaumont, E. C., Dahan, L. E., Alpert, J. E., et al. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04603 · Cited by 99
Mischoulon, D., Nierenberg, A. A., Schettler, P. J., Kinkead, B. L., Fehling, K., Martinson, M. A., & Rapaport, M. H. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m08986 · Cited by 76
Rondanelli, M., Giacosa, A., Opizzi, A., Pelucchi, C., Vecchia, C. L., Montorfano, G., Negroni, M., Berra, B., Politi, P., & Rizzo, A. M. (2011) · The journal of nutrition health & aging · doi:10.1007/s12603-011-0011-y · Cited by 75
Rizzo, A. M., Corsetto, P. A., Montorfano, G., Opizzi, A., Faliva, M. A., Giacosa, A., Ricevuti, G., Pelucchi, C., Berra, B., & Rondanelli, M. (2012) · Nutrition Journal · doi:10.1186/1475-2891-11-82 · Cited by 69
Kuan, C.-Y., Walker, T., Luo, P. G., & Chen, C. (2011) · Journal of the American College of Nutrition · doi:10.1080/07315724.2011.10719969 · Cited by 68
Gharekhani, A., Khatami, M., Dashti‐Khavidaki, S., Razeghi, E., Noorbala, A.-A., Nazari, S. S. H., & Mansournia, M. A. (2014) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-014-1666-1 · Cited by 68
What's in Placebos: Who Knows? Analysis of Randomized, Controlled Trials
Golomb, B. A., Erickson, L. C., Koperski, S., Sack, D., Enkin, M. W., & Howick, J. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-8-201010190-00010 · Cited by 62
Bot, M., Pouwer, F., Assies, J., Jansen, E. H. J. M., Diamant, M., Snoek, F. J., Beekman, A. T. F., & de Jonge, P. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.04.008 · Cited by 61
Self-citationMocking, R. J. T., Assies, J., Lok, A., Ruhé, H. G., Koeter, M. W. J., Visser, I., Bockting, C., & Schene, A. H. (2012) · Lipids · doi:10.1007/s11745-012-3665-2 · Cited by 59
Self-citationGinty, A. T., & Conklin, S. M. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.05.072 · Cited by 49
Mocking, R. J. T., Verburg, H. F., Westerink, A. M., Assies, J., Vaz, F. M., Koeter, M. W. J., Ruhé, H. G., & Schene, A. H. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.04.027 · Cited by 45
Self-citationInteractions between tricyclic antidepressants and phospholipid bilayer membranes.
Fišar, Z. (2005) · PubMed · Cited by 39
Mocking, R. J. T., Assies, J., Bot, M., Jansen, E. H. J. M., Schene, A. H., & Pouwer, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049431 · Cited by 36
Self-citationPark, Y., Park, Y.-S., Kim, S. H., Oh, D. H., & Park, Y. C. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000377640 · Cited by 34
Declining efficacy in controlled trials of antidepressants: effects of placebo dropout
Schalkwijk, S., Undurraga, J., Tondo, L., & Baldessarini, R. J. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000224 · Cited by 34
Qiu, X., Tian, X., Yang, J., Dong, H., Zheng-Xue, Q., & Dong, Q. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s86581 · Cited by 26
Mocking, R. J. T., Lok, A., Assies, J., Koeter, M. W. J., Visser, I., Ruhé, H. G., Bockting, C., & Schene, A. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082980 · Cited by 21
Self-citationNeuroticism but Not Omega-3 Fatty Acid Levels Correlate with Early Responsiveness to Escitalopram
Fiedorowicz, J. G., Hale, N., Spector, A. A., & Coryell, W. H. (2010) · Annals of Clinical Psychiatry · doi:10.1177/104012371002200304 · Cited by 15
Cited by
Djuricic, I., & Calder, P. C. (2021) · Nutrients · doi:10.3390/nu13072421 · Cited by 1,015
Imaging the Role of Inflammation in Mood and Anxiety-related Disorders
Felger, J. C. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666171123201142 · Cited by 427
Layé, S., Nadjar, A., Joffre, C., & Bazinet, R. P. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014092 · Cited by 420
Very long-chain n -3 fatty acids and human health: fact, fiction and the future
Calder, P. C. (2018) · Proceedings of the Nutrition Society · doi:10.1017/s0029665117003950 · Cited by 419
Efficacy of omega-3 PUFAs in depression: A meta-analysis
Liao, Y., Xie, B., Zhang, H., He, Q., Guo, L., Subramanieapillai, M., Fan, B., Lu, C., & McIntyre, R. S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0515-5 · Cited by 404
Metadata
- Authors
- Mocking, R. J. T., Harmsen, I., Assies, J., Koeter, M. W. J., Ruhé, H. G., & Schene, A. H.
- Venue
- Translational Psychiatry
- Published
- 2016-03-15
- Volume
- 6
- Issue
- 3
- Pages
- e756-e756
- ISSN
- 2158-3188 (ISSN-L)
- OpenAlex
- W2298125421
- Cited by
- 279
- References
- 55
- FWCI
- 36.89
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.